Global Immuno-Oncology Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)

DELHI, India - Sept. 23, 2020 - PRLog -- The report titled "Global Immuno-Oncology Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)", provides an in-depth analysis of the global immuno-oncology market by value and by region. The report provides a detailed analysis of the immuno-oncology assays market by value, by region, by application, etc. The report also provides a regional analysis of the immuno-oncology market, including the following regions: North America and Rest of World. Also detailed regional analysis of immuno-oncology assays market, including regions: North America, Europe and APAC.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global immuno-oncology market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Region Coverage

North America
Asia Pacific
Europe
ROW

Company Coverage

Merck and Co.
Pfizer Inc.
Amgen
Roche Holding AG

Executive Summary

The global immuno-oncology market has increased at a significant growth during the year 2019 and projections are made that the market would rise in the next four years at a significant CAGR i.e. 2020-2024 tremendously. The immuno-oncology market is expected to increase due to the rising number of cancer cases, unhealthy changes in dietary patterns, higher investments in the research and development, growing approvals of medicines for the treatment of various types of cancer, etc. Yet the market faces some challenges such as development of pre-clinical models, side-effects post immunotherapy and the declining composite success rate of oncology clinical trials, etc.

The global immuno-oncology market also follows some market trends which includes the CAR-NKs, CAR-Ms, Next-Gen CARs, accelerating immuno-oncology research, evolution of biosimilars in oncology, purchasing and reimbursement actions globally, etc.

For further details, kindly visit :

https://www.daedal-research.com/pharma-healthcare/global-immuno-oncology-market-size-forecast-with-impact-analysis-of-covid-19-2020-2024

Rajeev Kumar

(Business Development Manager)

Address:  36 SFS Flats

Paschim Vihar

New Delhi-110063

Mobile: +91-9811715635

Tel: +91-120-4553017

Mail ID - info@daedal-research.com